全文获取类型
收费全文 | 14168篇 |
免费 | 1011篇 |
国内免费 | 746篇 |
专业分类
耳鼻咽喉 | 148篇 |
儿科学 | 84篇 |
妇产科学 | 46篇 |
基础医学 | 1121篇 |
口腔科学 | 178篇 |
临床医学 | 1970篇 |
内科学 | 3632篇 |
皮肤病学 | 41篇 |
神经病学 | 1380篇 |
特种医学 | 864篇 |
外科学 | 1058篇 |
综合类 | 2732篇 |
现状与发展 | 1篇 |
预防医学 | 398篇 |
眼科学 | 141篇 |
药学 | 1262篇 |
5篇 | |
中国医学 | 785篇 |
肿瘤学 | 79篇 |
出版年
2024年 | 55篇 |
2023年 | 204篇 |
2022年 | 370篇 |
2021年 | 519篇 |
2020年 | 476篇 |
2019年 | 440篇 |
2018年 | 450篇 |
2017年 | 418篇 |
2016年 | 458篇 |
2015年 | 516篇 |
2014年 | 962篇 |
2013年 | 1187篇 |
2012年 | 886篇 |
2011年 | 927篇 |
2010年 | 792篇 |
2009年 | 782篇 |
2008年 | 772篇 |
2007年 | 744篇 |
2006年 | 689篇 |
2005年 | 592篇 |
2004年 | 504篇 |
2003年 | 405篇 |
2002年 | 351篇 |
2001年 | 264篇 |
2000年 | 227篇 |
1999年 | 201篇 |
1998年 | 203篇 |
1997年 | 172篇 |
1996年 | 121篇 |
1995年 | 129篇 |
1994年 | 122篇 |
1993年 | 98篇 |
1992年 | 120篇 |
1991年 | 90篇 |
1990年 | 70篇 |
1989年 | 77篇 |
1988年 | 72篇 |
1987年 | 49篇 |
1986年 | 47篇 |
1985年 | 82篇 |
1984年 | 49篇 |
1983年 | 34篇 |
1982年 | 47篇 |
1981年 | 37篇 |
1980年 | 41篇 |
1979年 | 15篇 |
1978年 | 24篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1972年 | 4篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
11.
12.
以大鼠高脂血症及动脉粥样硬化模型观察鱼油的作用,并与舒降之、诺衡比较。鱼油组血清总胆固醇(TC)、甘油三酯(TG)、低密度脂蛋白胆固醇(LDL-C)及LDL-C/TC显著低于高脂组(均为P<0.01);生化与病理检查提示鱼油能防止肝内脂质沉积,减少肝组织脂质过氧化物水平;鱼油能明显抑制高脂饮食造成的早期动脉粥样硬化病变。鱼油降TG的作用与舒降之及诺衡无明显差异,降TC的效果优于诺衡(P<0.05),改变脂蛋白成分的作用不及舒降之与诺衡。研究表明鱼油能延缓大鼠高脂血症和动脉粥样硬化的发生与发展。 相似文献
13.
目的:观察喉罩全麻下行颈动脉狭窄的造影诊断及介入治疗术的临床效果。方法:择期DSA下颈动脉狭窄患者23例,年龄42-78岁,无明显肺部疾患及喉罩禁忌症患者,异丙酚(Pmpofol)泵入静脉全麻下插入喉罩完成手术,观察其不同时段的BP(MAP)、SpO2、HR、ECG(ST-Ⅱ)。结果:各时段的BP(MAP)、Sp02、HR、ECG(ST-Ⅱ)比较无显著性差异。结论:喉罩全麻在行颈动脉狭窄的造影诊断及介入治疗术的临床效果是肯定的。喉罩全麻颈动脉狭窄造影介入治疗 相似文献
14.
V. K. Sharma G. Tsivgoulis A. Y. Lao M. Flaster J. L. Frey M. D. Malkoff A. V. Alexandrov 《European journal of neurology》2007,14(2):237-240
Although common carotid artery (CCA) occlusions are rare, acute clinical presentations vary from mild to devastating strokes primarily due to tandem occlusions in the intracranial arteries. Three patients with acute CCA occlusions were treated with systemic tissue plasminogen activator (TPA). Blood pressures were kept at the upper limits allowed with TPA therapy with fluid balance and the 'head-down' position. Recanalization occurred in intracranial vessels only. Marked early neurological improvement occurred in two of three patients. CCA occlusions should not be considered contra-indication to systemic thrombolysis. 相似文献
15.
Non-alcoholic fatty liver disease, the metabolic syndrome and the risk of cardiovascular disease: the plot thickens. 总被引:5,自引:0,他引:5
G Targher 《Diabetic medicine》2007,24(1):1-6
Non-alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the general population and is frequently associated with many features of the metabolic syndrome (MetS). Currently, the importance of NAFLD and its relationship with the MetS is being increasingly recognized, and this has stimulated an interest in the possible role of NAFLD in the development of atherosclerosis. Recent studies have reported the association of NAFLD with multiple classical and non-classical risk factors for cardiovascular disease (CVD). Moreover, there is a strong association between the severity of liver histopathology in NAFLD patients and greater carotid artery intima-media thickness and plaque, and lower endothelial flow-mediated vasodilation (as markers of subclinical atherosclerosis) independent of obesity and other MetS components. Finally, it has recently been demonstrated that NAFLD is associated with an increased risk of all-cause death and predicts future CVD events independently of other prognostic factors, including MetS components. Overall, therefore, the evidence from these recent studies strongly emphasizes the importance of assessing the global CVD risk in patients with NAFLD. Moreover, these novel findings suggest a more complex picture and raise the possibility that NAFLD, as a component of the MetS, might not only be a marker but also an early mediator of CVD. 相似文献
16.
17.
目的:研究载脂蛋白E(ApoE)基因多态性与颈动脉粥样硬化的相关性。方法:应用聚合酶链反应-限制性片段长度多态性(PCR-RFLP)技术,对25例B超检测颈动脉内中膜厚度(IMT)增厚患者(增厚组)和25例同期健康体检者(对照组)的ApoE基因多态性进行分析。结果:IMT增厚组ε3等位基因频率较对照组降低(P<0.05),ε4等位基因频率较对照组升高(P<0.01)。IMT增厚组的ε3/ε4基因型频率显著要高于对照组。对以上两组再按ApoE基因型分别分为3组:ApoE2(ε2/2 ε2/3),ApoE3(ε3/3)和ApoE4(ε3/4 ε4/4)。结果显示颈动脉IMT在不同基因型间差异显著,ApoE4组显著增加,颈动脉多发斑块率在此组也显著增加。结论:ApoE基因多态性与颈动脉粥样硬化形成有相关性,ε4基因是颈动脉粥样硬化形成的危险因子。 相似文献
18.
目的 :探讨二维彩色多普勒超声及彩色血管三维超声在颈动脉疾病的诊断价值。材料方法 :疑为缺血性脑卒中患者 80例 ,行颈动脉彩色多普勒超声检查 ,其中 2 8例同时做彩色血管三维超声成像 ,5 5例经临床、CT、MRI证实为脑梗死。结果 :①本组 5 5例脑梗死 ,彩色多普勒超声发现 4 9例颈动脉粥样硬化斑。②有脑梗死的彩色血管三维血流图呈“串珠”状 ,而非脑梗死的彩色血管三维血流图呈连续“圆锥”状。结论 :彩色多普勒超声诊断颈动脉粥样硬化有良好的价值 ,三维彩超是二维彩色多普勒超声的有益补充。 相似文献
19.
目的 探讨脂蛋白残粒RLP-c作为新的脂质指标的临床意义。方法 采用免疫分离法测定正常对照组(NC)、冠心病组(CHD)和2型糖尿病组(T2DM)的RLP-c水平,并比较RLP-c与其他脂质指标的相关性。结果 CHD组和T2DM组RLP-c水平明显高于NC组(P<0.01),其水平与甘油三脂(TG)和极低密度脂蛋白胆固醇(VLDL-c)高度相关(P<0.01)。结论 RLP-c可用于对动脉粥样硬化的危险性评估。 相似文献
20.
Aims To measure the prevalence of low high‐density lipoprotein (HDL)‐cholesterol (men < 1.03 mmol/l; women < 1.29 mmol/l) in European Type 2 diabetic patients receiving treatment for dyslipidaemia. Methods The pan‐European Survey of HDL‐cholesterol measured lipids and other cardiovascular risk factors in 3866 patients with Type 2 diabetes and 4436 non‐diabetic patients undergoing treatment for dyslipidaemia in 11 European countries. Results Diabetic patients were more likely to be obese or hypertensive than non‐diabetic patients. Most patients received lifestyle interventions (87%) and/or a statin (89%); treatment patterns were similar between groups. Diabetic patients had [means (SD)] lower HDL‐cholesterol [1.22 (0.37) vs. 1.35 mmol/l (0.44) vs. non‐diabetic patients, P < 0.001] and higher triglycerides [2.32 (2.10) vs. 1.85 mmol/l (1.60), P < 0.001]. More diabetic vs. non‐diabetic patients had low HDL‐cholesterol (45% vs. 30%), high triglycerides (≥ 1.7 mmol/l; 57% vs. 42%) or both (32% vs. 19%). HDL‐cholesterol < 0.9 mmol/l was observed in 18% of diabetic and 12% of non‐diabetic subjects. Differences between diabetic and non‐diabetic groups were slightly greater for women. LDL‐ and total cholesterol were lower in the diabetic group [3.02 (1.05) vs. 3.30 mmol/l (1.14) and 5.12 (1.32) vs. 5.38 mmol/l (1.34), respectively, P < 0.001 for each]. Conclusions Low HDL‐cholesterol is common in diabetes: one in two diabetic women has low HDL‐cholesterol and one diabetic man in four has very low HDL‐cholesterol. Management strategies should include correction of low HDL‐cholesterol to optimize cardiovascular risk in diabetes. 相似文献